伦敦和泰国曼谷, July 04, 2023 (GLOBE NEWSWIRE) -- 专注于生命科学领域的私募公司Aztiq Pharma Partners（“Aztiq”）及泰国石油天然气集团PTT Public Company Limited（“PTT”）的生命科学事业部Innobic (Asia) Company Limited（“Innobic”）（合称“股东”）今日宣布，以每股新台币297元的价格出售25,095,850股跨国制药公司Lotus Pharmaceuticals（1795：TT；“ …
倫敦和泰國曼谷, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners（「Aztiq」)是一家專注於生命科學行業的私募股權公司，其與泰國石油和天然氣企業集團PTT Public Company Limited（「PTT」）的生命科學業務分支Innobic (Asia) Company Limited（「Innobic」）（統稱「股東」）今日宣佈出售跨國製藥公司Lotus Pharmaceuticals（1795:TT；「Lotus」、「公司」）25, …
LONDON and BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), a private equity company focused on the life sciences sector, and Innobic (Asia) Company Limited (“Innobic”), the life science arm of Thai oil and gas …
REYKJAVIK, Iceland, June 28, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration …
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech ( …
HEMPE sponsor 2023 World Strength Games and Adaptive Strength World Championships, promoting natural natural pain relief alternatives and supporting athletes. WIMBORNE, DORSET, UNITED KINGDOM, May 31, 2023 /EINPresswire.com/ -- HEMPE Announced as Master …
REYKJAVIK, Iceland, May 31, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …
Advanz Pharma secures exclusive rights from Alvotech to commercialize five proposed biosimilars in Europe The agreement includes proposed biosimilars to Simponi® (golimumab), Entyvio® (vedolizumab) and three additional early-stage undisclosed biosimilar …
Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period in 2022 Confirmatory patient study for AVT05, a proposed biosimilar for Simponi® and Simponi Aria® (golimumab) initiated, marking the fifth …
REYKJAVIK, Iceland, May 17, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley …
Alvotech’s global workforce is now evenly split between females and males, and the unexplained gender pay gap has been reduced to 1.6% from 5.2% in December 2020 Alvotech’s Equality Policy, which is based on Icelandic law, has been implemented for the …
Polifarma will commercialize AVT06, a proposed biosimilar to Eylea® (aflibercept), in Turkey REYKJAVIK, Iceland, May 10, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of …
The clinical study will compare AVT05 and Simponi® in patients with moderate to severe rheumatoid arthritis REYKJAVIK, Iceland, May 04, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and …
REYKJAVIK, Iceland, May 03, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for …
REYKJAVIK, Iceland, April 19, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to the company’s Quality unit. …
REYKJAVIK, Iceland, April 14, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug …
TOKYO and LONDON, April 12, 2023 (GLOBE NEWSWIRE) -- Mitsui & Co., Ltd. ("Mitsui") has acquired convertible bonds worth approximately US $62.75 million (¥8.6 billion) issued by Luxembourg-based Alvotech S.A. (“Alvotech”) from ATP Holdings ehf …
L.A.B ANNOUNCE THEIR TOUR DATES FOR 2023 AS THEIR SINGLE, ‘TAKE IT AWAY’ BECOMES THEIR LATEST HIT LONDON, UNITED KINGDOM, April 6, 2023 /EINPresswire.com/ -- ‘Take It Away’ brings together all elements of the L.A.B sound - reggae-inspired groove, …
Revolutionary EndoSure Test set to transform endometriosis diagnosis & treatment across Norway, Sweden, Denmark, and Iceland. SPARKS GLENCOE, MARYLAND, UNITED STATES, April 3, 2023 /EINPresswire.com/ -- ENDOSURE, Inc. appoints Ferdinand Medical ApS …
First-to-market innovative AI technology enables users to write press releases. WASHINGTON , D.C., USA, March 28, 2023 /EINPresswire.com/ -- EIN Presswire, a division of Newsmatics Inc., announced the launch of its groundbreaking AI-powered "Press …
02 days 19:13:27
